Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)

Abstract Background Tuberous sclerosis complex (TSC) is a rare multisystem autosomal dominant disorder caused by pathogenic variants in either the TSC1 or TSC2 gene. Common manifestations of TSC have been grouped into major and minor clinical diagnostic criteria and assessed in clinical routine work...

Full description

Bibliographic Details
Main Authors: Matthias Sauter, Elena Belousova, Mirjana P. Benedik, Tom Carter, Vincent Cottin, Paolo Curatolo, Maria Dahlin, Lisa D’Amato, Guillaume B. d’Augères, Petrus J. de Vries, José C. Ferreira, Martha Feucht, Carla Fladrowski, Christoph Hertzberg, Sergiusz Jozwiak, John A. Lawson, Alfons Macaya, Ruben Marques, Rima Nabbout, Finbar O’Callaghan, Jiong Qin, Valentin Sander, Seema Shah, Yukitoshi Takahashi, Renaud Touraine, Sotiris Youroukos, Bernard Zonnenberg, Anna Jansen, J. Chris Kingswood, the TOSCA investigators
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-021-01917-y
_version_ 1819156730973519872
author Matthias Sauter
Elena Belousova
Mirjana P. Benedik
Tom Carter
Vincent Cottin
Paolo Curatolo
Maria Dahlin
Lisa D’Amato
Guillaume B. d’Augères
Petrus J. de Vries
José C. Ferreira
Martha Feucht
Carla Fladrowski
Christoph Hertzberg
Sergiusz Jozwiak
John A. Lawson
Alfons Macaya
Ruben Marques
Rima Nabbout
Finbar O’Callaghan
Jiong Qin
Valentin Sander
Seema Shah
Yukitoshi Takahashi
Renaud Touraine
Sotiris Youroukos
Bernard Zonnenberg
Anna Jansen
J. Chris Kingswood
the TOSCA investigators
author_facet Matthias Sauter
Elena Belousova
Mirjana P. Benedik
Tom Carter
Vincent Cottin
Paolo Curatolo
Maria Dahlin
Lisa D’Amato
Guillaume B. d’Augères
Petrus J. de Vries
José C. Ferreira
Martha Feucht
Carla Fladrowski
Christoph Hertzberg
Sergiusz Jozwiak
John A. Lawson
Alfons Macaya
Ruben Marques
Rima Nabbout
Finbar O’Callaghan
Jiong Qin
Valentin Sander
Seema Shah
Yukitoshi Takahashi
Renaud Touraine
Sotiris Youroukos
Bernard Zonnenberg
Anna Jansen
J. Chris Kingswood
the TOSCA investigators
author_sort Matthias Sauter
collection DOAJ
description Abstract Background Tuberous sclerosis complex (TSC) is a rare multisystem autosomal dominant disorder caused by pathogenic variants in either the TSC1 or TSC2 gene. Common manifestations of TSC have been grouped into major and minor clinical diagnostic criteria and assessed in clinical routine workup. However, case studies point towards the existence of rare disease manifestations and to the potential association of TSC with malignant tumors. In this study we sought to characterize rare manifestations and malignancies using a large cohort of patients. Methods TuberOus SClerosis registry to increAse disease awareness (TOSCA) is a multicenter, international disease registry collecting clinical manifestations and characteristics of patients with TSC, both retrospectively and prospectively. We report rates and characteristics of rare manifestations and malignancies in patients with TSC who had enrolled in the TOSCA registry. We also examined these manifestations by age, sex, and genotype (TSC1 or TSC2). Results Overall, 2211 patients with TSC were enrolled in the study. Rare manifestations were reported in 382 (17.3%) study participants and malignancies in 65 (2.9%). Of these rare manifestations, the most frequent were bone sclerotic foci (39.5%), scoliosis (23%), thyroid adenoma (5.5%), adrenal angiomyolipoma (4.5%), hemihypertrophy and pancreatic neuroendocrine tumors (pNET; both 3.1%). These rare manifestations were more commonly observed in adults than children (66.2% vs. 22.7%), in females versus males (58.4% vs. 41.6%; except for scoliosis: 48.9% vs. 51.1%), and in those with TSC2 versus TSC1 (67.0% vs. 21.1%; except for thyroid adenoma: 42.9% vs. 57.1%). In the 65 individuals with reported malignancies, the most common were renal cell carcinoma (47.7%), followed by breast (10.8%) and thyroid cancer (9.2%). Although malignancies were more common in adult patients, 26.1% were reported in children and 63.1% in individuals < 40 years. TSC1 mutations were over-represented in individuals with malignancies compared to the overall TOSCA cohort (32.1% vs. 18.5%). Conclusion Rare manifestations were observed in a significant proportion of individuals with TSC. We recommend further examination of rare manifestations in TSC. Collectively, malignancies were infrequent findings in our cohort. However, compared to the general population, malignant tumors occurred earlier in age and some tumor types were more common.
first_indexed 2024-12-22T15:57:31Z
format Article
id doaj.art-3dc0f80054b74f879b4183fb55c67671
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-12-22T15:57:31Z
publishDate 2021-07-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-3dc0f80054b74f879b4183fb55c676712022-12-21T18:20:44ZengBMCOrphanet Journal of Rare Diseases1750-11722021-07-0116111510.1186/s13023-021-01917-yRare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)Matthias Sauter0Elena Belousova1Mirjana P. Benedik2Tom Carter3Vincent Cottin4Paolo Curatolo5Maria Dahlin6Lisa D’Amato7Guillaume B. d’Augères8Petrus J. de Vries9José C. Ferreira10Martha Feucht11Carla Fladrowski12Christoph Hertzberg13Sergiusz Jozwiak14John A. Lawson15Alfons Macaya16Ruben Marques17Rima Nabbout18Finbar O’Callaghan19Jiong Qin20Valentin Sander21Seema Shah22Yukitoshi Takahashi23Renaud Touraine24Sotiris Youroukos25Bernard Zonnenberg26Anna Jansen27J. Chris Kingswood28the TOSCA investigatorsKlinikum KemptenResearch and Clinical Institute of Pediatrics, Pirogov Russian National Research Medical UniversitySPS Pediatrična KlinikaTSA Tuberous Sclerosis AssociationHôpital Louis PradelTor Vergata University HospitalKarolinska University HospitalNovartis Farma S.P.AAssociation Sclérose Tubéreuse de BournevilleDivision of Child and Adolescent Psychiatry, University of Cape TownCentro Hospitalar Lisboa OcidentalUniversitätsklinik Für Kinder-Und Jugendheilkunde (Affiliated Partner of the ERN EpiCARE)Associazione Sclerosi Tuberosa ONLUSVivantes-Klinikum NeuköllnDepartment of Child Neurology, Medical University of WarsawThe Tuberous Sclerosis Multidisciplinary Management Clinic, Sydney Children’s HospitalHospital Universitari Vall D’HebronNovartis Farma S.P.ADepartment of Pediatric Neurology, Necker Enfants Malades Hospital, Imagine Institute, Paris Descartes UniversityInstitute of Child Health, University College LondonDepartment of Pediatrics, Peking University People’s HospitalTallinn Children HospitalNovartis Healthcare Pvt. LtdNational Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological DisordersDepartment of Genetics, CHU-Hôpital NordSt. Sophia Children’s HospitalUniversity Medical CenterPediatric Neurology Unit, Department of Pediatrics, UZ Brussel VUBCardiology Clinical Academic Group, Molecular and Clinical Sciences Research Centre, St Georges University of LondonAbstract Background Tuberous sclerosis complex (TSC) is a rare multisystem autosomal dominant disorder caused by pathogenic variants in either the TSC1 or TSC2 gene. Common manifestations of TSC have been grouped into major and minor clinical diagnostic criteria and assessed in clinical routine workup. However, case studies point towards the existence of rare disease manifestations and to the potential association of TSC with malignant tumors. In this study we sought to characterize rare manifestations and malignancies using a large cohort of patients. Methods TuberOus SClerosis registry to increAse disease awareness (TOSCA) is a multicenter, international disease registry collecting clinical manifestations and characteristics of patients with TSC, both retrospectively and prospectively. We report rates and characteristics of rare manifestations and malignancies in patients with TSC who had enrolled in the TOSCA registry. We also examined these manifestations by age, sex, and genotype (TSC1 or TSC2). Results Overall, 2211 patients with TSC were enrolled in the study. Rare manifestations were reported in 382 (17.3%) study participants and malignancies in 65 (2.9%). Of these rare manifestations, the most frequent were bone sclerotic foci (39.5%), scoliosis (23%), thyroid adenoma (5.5%), adrenal angiomyolipoma (4.5%), hemihypertrophy and pancreatic neuroendocrine tumors (pNET; both 3.1%). These rare manifestations were more commonly observed in adults than children (66.2% vs. 22.7%), in females versus males (58.4% vs. 41.6%; except for scoliosis: 48.9% vs. 51.1%), and in those with TSC2 versus TSC1 (67.0% vs. 21.1%; except for thyroid adenoma: 42.9% vs. 57.1%). In the 65 individuals with reported malignancies, the most common were renal cell carcinoma (47.7%), followed by breast (10.8%) and thyroid cancer (9.2%). Although malignancies were more common in adult patients, 26.1% were reported in children and 63.1% in individuals < 40 years. TSC1 mutations were over-represented in individuals with malignancies compared to the overall TOSCA cohort (32.1% vs. 18.5%). Conclusion Rare manifestations were observed in a significant proportion of individuals with TSC. We recommend further examination of rare manifestations in TSC. Collectively, malignancies were infrequent findings in our cohort. However, compared to the general population, malignant tumors occurred earlier in age and some tumor types were more common.https://doi.org/10.1186/s13023-021-01917-yRare manifestationMalignancyTOSCATSCTuberous sclerosis complex
spellingShingle Matthias Sauter
Elena Belousova
Mirjana P. Benedik
Tom Carter
Vincent Cottin
Paolo Curatolo
Maria Dahlin
Lisa D’Amato
Guillaume B. d’Augères
Petrus J. de Vries
José C. Ferreira
Martha Feucht
Carla Fladrowski
Christoph Hertzberg
Sergiusz Jozwiak
John A. Lawson
Alfons Macaya
Ruben Marques
Rima Nabbout
Finbar O’Callaghan
Jiong Qin
Valentin Sander
Seema Shah
Yukitoshi Takahashi
Renaud Touraine
Sotiris Youroukos
Bernard Zonnenberg
Anna Jansen
J. Chris Kingswood
the TOSCA investigators
Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
Orphanet Journal of Rare Diseases
Rare manifestation
Malignancy
TOSCA
TSC
Tuberous sclerosis complex
title Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
title_full Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
title_fullStr Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
title_full_unstemmed Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
title_short Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
title_sort rare manifestations and malignancies in tuberous sclerosis complex findings from the tuberous sclerosis registry to increase disease awareness tosca
topic Rare manifestation
Malignancy
TOSCA
TSC
Tuberous sclerosis complex
url https://doi.org/10.1186/s13023-021-01917-y
work_keys_str_mv AT matthiassauter raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT elenabelousova raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT mirjanapbenedik raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT tomcarter raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT vincentcottin raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT paolocuratolo raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT mariadahlin raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT lisadamato raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT guillaumebdaugeres raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT petrusjdevries raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT josecferreira raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT marthafeucht raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT carlafladrowski raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT christophhertzberg raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT sergiuszjozwiak raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT johnalawson raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT alfonsmacaya raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT rubenmarques raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT rimanabbout raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT finbarocallaghan raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT jiongqin raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT valentinsander raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT seemashah raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT yukitoshitakahashi raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT renaudtouraine raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT sotirisyouroukos raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT bernardzonnenberg raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT annajansen raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT jchriskingswood raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca
AT thetoscainvestigators raremanifestationsandmalignanciesintuberoussclerosiscomplexfindingsfromthetuberoussclerosisregistrytoincreasediseaseawarenesstosca